CLBIO.STCLBIO.STSTO
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+52.3%
5Y CAGR-36.4%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+52.3%/yr
Quarterly compound
5Y CAGR
-36.4%/yr
Recent acceleration
Percentile
P82
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 61.23% |
| Q3 2025 | -40.33% |
| Q2 2025 | 6.42% |
| Q1 2025 | 2.14% |
| Q4 2024 | 13.67% |
| Q3 2024 | -21.51% |
| Q2 2024 | -39.67% |
| Q1 2024 | -40.13% |
| Q4 2023 | 17.59% |
| Q3 2023 | -12.64% |
| Q2 2023 | -17.84% |
| Q1 2023 | -10.27% |
| Q4 2022 | 17.32% |
| Q3 2022 | 34.97% |
| Q2 2022 | 69.61% |
| Q1 2022 | -5.25% |
| Q4 2021 | 236.80% |
| Q3 2021 | -27.45% |
| Q2 2021 | -13.56% |
| Q1 2021 | -39.51% |
| Q4 2020 | 589.13% |
| Q3 2020 | -38.77% |
| Q2 2020 | 214.66% |
| Q1 2020 | -54.20% |
| Q4 2019 | 202.17% |
| Q3 2019 | -62.60% |
| Q2 2019 | 163.57% |
| Q1 2019 | -74.31% |
| Q4 2018 | 50.55% |
| Q3 2018 | 4.62% |
| Q2 2018 | 11.61% |
| Q1 2018 | 58.16% |
| Q4 2017 | 60.66% |
| Q3 2017 | 18.45% |
| Q2 2017 | -52.53% |
| Q1 2017 | 5.34% |
| Q4 2016 | 30.38% |
| Q3 2016 | -56.95% |
| Q2 2016 | 68.61% |
| Q1 2016 | 45.24% |